FDA Inspection
PD-Rx Pharmaceuticals, Inc.PD-Rx Pharmaceuticals, Inc. – FDA Inspection, Aug 20, 2026
Record Details
This FDA Inspection record concerns PD-Rx Pharmaceuticals, Inc., with an inspection on August 20, 2026, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 66259774-13a6-46b1-aa9f-25aa061606c0
Inspection Facts
- Inspection number
- 1331942
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PD-Rx Pharmaceuticals, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 21, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PD-Rx Pharmaceuticals, Inc.
- FDA Inspection 1190289 - 2022-11-10
- FDA Inspection 955661 - 2015-12-04
- FDA Inspection 593127 - 2009-05-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.